Advancements to include CosMx® Whole Transcriptome Panel; enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of PaintScape™, a revolutionary platform enabling direct visualization of the 3D genome
BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. Bruker Spatial Biology will announce the following four innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering, best-in-class platforms:
RNA transcripts in human hippocampus FFPE tissue assayed with the CosMx Whole Transcriptome Panel
- the first and only Whole Transcriptome Panel (WTX) on the subcellular resolution CosMx Spatial Molecular Imager (SMI) platform,
- the new PaintScape platform for direct visualization of the 3D genome,
- the new CellScape PowerOMX™ software engine, developed to optimize the performance of the new EpicIF technology on the CellScape spatial proteomics platform,
- a doubling of the GeoMx protein panel to an unprecedented 1,000 plexfor the highest level of tissue multiomics